Jan 19, 2026
10:1
For every share held, investors received 10. The price per share adjusted from $185.00 to $18.50.
The split itself did not change the total investment value.
Daiken Biomedical Co., Ltd. (TWSE:7780) operates in the Pharmaceuticals: other industry.
Daiken Biomedical Co., Ltd. company overviewDaiken Biomedical Co., Ltd.'s most recent stock split was on January 19, 2026. It was a 10-for-1 forward split, so shareholders received 10 shares for every share they held.
Daiken Biomedical Co., Ltd. has split its stock once. This history records one forward split, on January 19, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Daiken Biomedical Co., Ltd.'s 10-for-1 split on January 19, 2026, every share became 10 shares.
Daiken Biomedical Co., Ltd. has not announced a new split in our records. Its most recent split was on January 19, 2026, less than a year ago. Companies announce splits in advance, and any new TWSE:7780 split will appear on this page.
Already premium?